Proactive Resource Group, an LSPedia, Inc. company, is offering fractional and outsourced DSCSA services to help pharmaceutical companies comply with the requirements of the FDA’s Drug Supply Chain Security Act (DSCSA).

Under DSCSA, pharmaceutical companies must track and trace products through the supply chain by exchanging transaction information, history, and statement data, a process encompassing multiple complex and time-consuming tasks.

In a statement, Proactive Resource Group’s said that its team of experts has extensive experience in DSCSA compliance, including electronic product code information services (EPCIS) data exchange, trading partner onboarding, and exceptions management. Proactive offers EPCIS support to guarantee that any pharmaceutical company can meet the FDA’s upcoming DSCSA enforcement deadline on November 27, 2023.

By outsourcing DSCSA services to Proactive Resource Group, pharmaceutical companies can streamline EPCIS onboarding, reduce errors, and ensure ongoing compliance with DSCSA requirements, according to the company.

Proactive Resource Group’s services include exceptions management, LSPedia Investigator processes, DSCSA training, project management, and more. Its team carries out communications and testing with trading partners, and provides support in identifying, investigating, and resolving any exceptions that occur in supply chain operations. Additionally, it continuously monitors a customer’s supply chain processes to align them with internal quality system requirements, including record-keeping, reporting, policies, and SOPs.

Pharmaceutical companies also have direct access to a team of experienced professionals who have a deep understanding of the complexities of DSCSA, helping customers meet the FDA’s enforcement deadline.

Jay Madden, director of national accounts, ACI Healthcare, said, “I don’t have time to check EPCIS for errors. Proactive Resource’s DSCSA services took a lot of burden away from us, which gives me more time to generate revenue.”